| SpectraBase Spectrum ID |
ADysglFBV19 |
| Name |
2-Benzylamino-1-(3,4-methylenedioxyphenyl)butan-1-one |
| Classification |
Cathinone analog designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
297.136493473 u |
| Formula |
C18H19NO3 |
| InChI |
InChI=1S/C18H19NO3/c1-2-15(19-11-13-6-4-3-5-7-13)18(20)14-8-9-16-17(10-14)22-12-21-16/h3-10,15,19H,2,11-12H2,1H3 |
| InChIKey |
ROBPFIVMZCNMJW-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
297.354 g/mol |
| Nominal Mass |
297 u |
| Quality |
999 |
| Retention Index |
2392 |
| SMILES |
C=1(C(C(NCC=2C=CC=CC2)CC)=O)C=C2C(=CC1)OCO2 |
| SPLASH |
splash10-0005-9700000000-266f007ca9ff9a1b4375 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
BMDB
N-Benzylnorbutylone
1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)butan-1-one |
| Technique |
GC/MS |
| Wiley ID |
DD2024_016330 |
